The PBS

News Hour Podcast is supported in part by Dana Farber Cancer Institute. What if we could block a protein to stop runaway cell division?

Dana Farber Cancer Institute laid the foundation for CDK46 inhibitors.

Drugs designed to treat many advanced breast cancers.

Learn more at DanaFarber.org

slash everywhere. As Ukraine marks two years of war with Russia, American support for aid in the country,

to the country rather, is wavering along partisan battle lines.

On that and the other political story shaping the week,

we turn now to the analysis of Brooks and Kapart.

That is New York Times columnist David Brooks

and Jonathan Kapart, associate editor for the Washington Post.

Great to see you both.

Let's start with Ukraine.

Russia's war, David, as you know, now moving into its third year there.

Russia is clearly gaining momentum on the battlefield.

Lawmakers here in the U.S. are unable to move through aid.

Mr. Trump is now telling Republicans not to back that aid.

If the Ukraine war was supposed to be this test, test right of Western democracies coming together

showing their strength against a rising autocracy. Are we failing that test?

Well we're on the verge of it. You know if you had told me two years ago that

Europe would be united and strong and

in support even though they were so dependent on Russian energy and that we'd be

...